- Home
- ORIC vs ECX Comparison
ORIC vs ECX Comparison
Compare ORIC & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | ECX |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 412.6M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ORIC | ECX |
|---|---|---|
| Price | $12.45 | $0.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | ★ $21.08 | $3.05 |
| AVG Volume (30 Days) | ★ 1.3M | 975.2K |
| Earning Date | 11-12-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.03 |
| Revenue Next Year | N/A | $18.65 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $0.88 |
| 52 Week High | $14.93 | $2.70 |
Technical Indicators
Market Signals| Indicator | ORIC | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 43.70 | 29.29 |
| Support Level | $10.17 | N/A |
| Resistance Level | $12.59 | $1.14 |
| Average True Range (ATR) | 0.73 | 0.06 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 26.54 | 4.02 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China. The companies core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.